HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New blood test could spare throat cancer patients harsh radiation
Disease control Recruiting nowThis study is testing a new approach for people with HPV-related throat cancer who have surgery. Researchers want to see if a simple blood test can identify patients who are unlikely to need follow-up radiation. If the blood test after surgery shows no signs of leftover cancer, p…
Matched conditions: HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Apr 01, 2026 23:11 UTC
-
Blood test could spare cancer patients harsh radiation
Disease control Recruiting nowThis study is testing if a blood test that looks for tiny bits of cancer DNA can help doctors decide which patients need radiation after surgery for HPV-related throat cancer. The goal is to see if some patients can safely delay radiation or receive a shorter course of treatment.…
Matched conditions: HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 23:11 UTC
-
New Two-Drug attack on tough head & neck cancers
Disease control Recruiting nowThis study is testing whether a combination of two drugs, sacituzumab govitecan and cetuximab, can help control advanced head and neck cancer that has come back or spread after initial treatment. It will involve about 40 adults whose cancer has progressed despite standard therapy…
Matched conditions: HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists test 'Living Drug' to fight HPV cancers
Disease control Recruiting nowThis study is testing a new personalized treatment for advanced cancers caused by HPV. Doctors take a patient's own immune cells, modify them in a lab to better target the cancer, and infuse them back to try to shrink tumors before standard therapy like chemo or surgery. The goal…
Matched conditions: HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New combo therapy aims to shrink tumors, cut harsh treatment for HPV-Linked throat cancer
Disease control Recruiting nowThis study is testing whether adding two new, experimental drugs (HB-201 and HB-202) to standard chemotherapy can better shrink tumors in people with HPV16-positive throat cancer. The goal is to see if this stronger initial treatment allows doctors to safely use less radiation or…
Matched conditions: HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Engineered immune cells target HPV cancers in new trial
Disease control Recruiting nowThis study is testing a new gene therapy for people with advanced cancers caused by HPV. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack HPV-infected cancer cells, and then infuse them back into the patient. The goal is to see if thi…
Matched conditions: HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Experimental vaccine aims to train immune system to fight HPV cancers
Disease control Recruiting nowThis clinical trial is testing a new vaccine called Lenti-HPV-07 for people with HPV-related throat or cervical cancer. The study aims to see if the vaccine is safe and can trigger the immune system to fight cancer cells. Researchers will enroll 72 participants and follow them fo…
Matched conditions: HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Theravectys S.A. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Doctors test cutting radiation for Fast-Responding HPV throat cancers
Disease control Recruiting nowThis study is testing if doctors can safely lower the dose of radiation and chemotherapy for people with HPV-positive throat cancer who show a good response halfway through treatment. The goal is to see if patients who get less treatment have similar cancer control and survival r…
Matched conditions: HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC